Literature DB >> 15982853

Autocrine, paracrine and juxtacrine signaling by EGFR ligands.

Amar B Singh1, Raymond C Harris.   

Abstract

Receptor and cytoplasmic protein tyrosine kinases play prominent roles in the control of a range of cellular processes during embryonic development and in the regulation of many metabolic and physiological processes in a variety of tissues and organs. The epidermal growth factor receptor (EGFR) is a well-known and versatile signal transducer that has been highly conserved during evolution. It functions in a wide range of cellular processes, including cell fate determination, proliferation, cell migration and apoptosis. The number of ligands that can activate the EGF receptor has increased during evolution. These ligands are synthesized as membrane-anchored precursor forms that are later shed by metalloproteinase-dependent cleavage to generate soluble ligands. In certain circumstances the membrane anchored isoforms as well as soluble growth factors may also act as biologically active ligands; therefore depending on the circumstances these ligands may induce juxtacrine, autocrine, paracrine and/or endocrine signaling. In this review, we discuss the different ways that EGFR ligands can activate the receptor and the possible biological implications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15982853     DOI: 10.1016/j.cellsig.2005.03.026

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  130 in total

1.  Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context.

Authors:  Elizabeth J Joslin; Harish Shankaran; Lee K Opresko; Nikki Bollinger; Douglas A Lauffenburger; H Steven Wiley
Journal:  Mol Biosyst       Date:  2010-05-10

2.  The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release.

Authors:  Robin N Prince; Eric R Schreiter; Peng Zou; H Steven Wiley; Alice Y Ting; Richard T Lee; Douglas A Lauffenburger
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

3.  Amphiregulin exosomes increase cancer cell invasion.

Authors:  James N Higginbotham; Michelle Demory Beckler; Jonathan D Gephart; Jeffrey L Franklin; Galina Bogatcheva; Gert-Jan Kremers; David W Piston; Gregory D Ayers; Russell E McConnell; Matthew J Tyska; Robert J Coffey
Journal:  Curr Biol       Date:  2011-04-21       Impact factor: 10.834

Review 4.  Cell-specific aptamer-mediated targeted drug delivery.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Oligonucleotides       Date:  2010-12-23

Review 5.  Extracellular vesicles in breast cancer drug resistance and their clinical application.

Authors:  Shentong Yu; Yifang Wei; Yuqiao Xu; Yuan Zhang; Jipeng Li; Jian Zhang
Journal:  Tumour Biol       Date:  2016-01-21

Review 6.  Keeping stem cells under control: New insights into the mechanisms that limit niche-stem cell signaling within the reproductive system.

Authors:  Mayu Inaba; Yukiko M Yamashita; Michael Buszczak
Journal:  Mol Reprod Dev       Date:  2016-08       Impact factor: 2.609

7.  Using information theory to assess the communicative capacity of circulating microRNA.

Authors:  Nnenna A Finn; Charles D Searles
Journal:  Biochem Biophys Res Commun       Date:  2013-08-27       Impact factor: 3.575

Review 8.  Signaling components of redox active endosomes: the redoxosomes.

Authors:  Fredrick D Oakley; Duane Abbott; Qiang Li; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

9.  Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).

Authors:  Brittany L Carpenter; Min Chen; Teresa Knifley; Kelley A Davis; Susan M W Harrison; Rachel L Stewart; Kathleen L O'Connor
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

Review 10.  Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Annu Rev Physiol       Date:  2013-11-08       Impact factor: 19.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.